Bioceres Crop Solutions Corp (BIOX)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NASDAQ
Market Cap: $13.40M
Last updated: Nov 17, 2026 at 10:59 AM ET
Bioceres Crop Solutions Corp (BIOX) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Bioceres Crop Solutions reported EPS of -$0.16. It beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
BIOX's next report is not on the earnings calendar yet.
BIOX Earnings Call
The latest BIOX earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 27 quarters below that had an estimate, BIOX beat 4 and missed 23. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 900.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 11, 2026 | N/A |
| Jun 30, 2026 | -$0.50 | -$0.06 | N/A | -733.33% | Miss | N/A | N/A | N/A | Sep 14, 2026 | $57.00M |
| Mar 31, 2026 | -$0.14 | -$0.05 | -$0.05 - -$0.05 | -180.00% | Miss | N/A | 1 | 0 up, 1 down | May 11, 2026 | $38.20M |
| Dec 31, 2025 | -$0.08 | $0.07 | $0.07 - $0.07 | -208.46% | Miss | -936.8% | 1 | 0 up, 1 down | Mar 13, 2026 | $73.67M |
| Sep 30, 2025 | -$0.12 | $0.03 | N/A | -494.33% | Miss | N/A | 3 | 0 up, 1 down | Nov 12, 2025 | $77.44M |
| Jun 30, 2025 | -$0.70 | $0.10 | $0.04 - $0.15 | -800.00% | Miss | N/A | 2 | 0 up, 1 down | Sep 9, 2025 | $74.40M |
| Mar 31, 2025 | -$0.02 | -$0.10 | -$0.15 - -$0.05 | +80.00% | Beat | -114.3% | 2 | 0 up, 1 down | May 21, 2025 | $59.60M |
| Dec 31, 2024 | $0.01 | $0.09 | $0.01 - $0.14 | -89.44% | Miss | -52.5% | 3 | 0 up, 1 down | Feb 11, 2025 | $98.88M |
| Sep 30, 2024 | -$0.09 | -$0.01 | -$0.14 - $0.10 | -800.00% | Miss | N/A | 4 | 0 up, 1 down | Nov 11, 2024 | $92.62M |
| Jun 30, 2024 | -$0.03 | $0.24 | $0.19 - $0.36 | -112.50% | Miss | N/A | 5 | 0 up, 0 down | Sep 9, 2024 | $124.31M |
| Mar 31, 2024 | $0.14 | $0.17 | $0.14 - $0.18 | -17.65% | Miss | -68.9% | 4 | 0 up, 0 down | May 13, 2024 | $84.00M |
| Dec 31, 2023 | $0.02 | $0.09 | $0.02 - $0.16 | -77.78% | Miss | N/A | 5 | 0 up, 0 down | Feb 8, 2024 | $140.30M |
| Sep 30, 2023 | -$0.07 | $0.04 | $0.03 - $0.10 | -275.00% | Miss | -800.0% | 4 | 0 up, 0 down | Nov 13, 2023 | $116.18M |
| Jun 30, 2023 | -$0.06 | $0.05 | -$0.01 - $0.14 | -220.00% | Miss | N/A | 5 | 0 up, 0 down | Sep 11, 2023 | $105.07M |
| Mar 31, 2023 | $0.45 | -$0.04 | -$0.09 - $0.03 | N/A | N/A | N/A | 5 | 0 up, 0 down | May 10, 2023 | $92.98M |
| Dec 31, 2022 | -$0.14 | $0.14 | -$0.04 - $0.24 | -200.00% | Miss | -275.0% | 4 | 0 up, 0 down | Feb 8, 2023 | $94.55M |
| Sep 30, 2022 | $0.01 | $0.05 | $0.01 - $0.09 | -80.00% | Miss | -50.0% | 5 | 0 up, 0 down | Nov 29, 2022 | $126.84M |
| Jun 30, 2022 | -$0.08 | $0.16 | -$0.09 - $0.33 | -150.00% | Miss | -500.0% | 3 | 0 up, 0 down | Sep 8, 2022 | $101.56M |
| Mar 31, 2022 | -$0.16 | $0.02 | N/A | -900.00% | Miss | N/A | 4 | 0 up, 0 down | May 27, 2022 | $68.23M |
| Dec 31, 2021 | $0.08 | $0.22 | -$0.38 - $0.27 | -63.64% | Miss | +300.0% | 4 | N/A | Feb 25, 2022 | $92.31M |
| Sep 30, 2021 | $0.02 | $0.10 | $0.01 - $0.15 | -80.00% | Miss | N/A | 4 | N/A | Nov 30, 2021 | $66.35M |
| Jun 30, 2021 | $0.02 | $0.27 | N/A | -92.59% | Miss | -60.0% | N/A | N/A | Sep 9, 2021 | $81.05M |
| Mar 31, 2021 | -$0.03 | -$0.05 | -$0.07 - -$0.03 | +40.00% | Beat | N/A | 2 | N/A | May 28, 2021 | $35.54M |
| Dec 31, 2020 | $0.02 | $0.36 | $0.36 - $0.36 | -94.44% | Miss | -93.5% | 1 | N/A | Feb 26, 2021 | $48.00M |
| Sep 30, 2020 | -$0.17 | $0.08 | $0.08 - $0.08 | -312.50% | Miss | N/A | 1 | N/A | Nov 30, 2020 | $42.11M |
| Jun 30, 2020 | $0.05 | $0.22 | $0.20 - $0.23 | -77.27% | Miss | N/A | 2 | N/A | Sep 28, 2020 | $48.13M |
| Mar 31, 2020 | -$0.09 | -$0.11 | -$0.14 - -$0.09 | +18.18% | Beat | N/A | 2 | N/A | May 28, 2020 | $25.72M |
| Dec 31, 2019 | $0.31 | $0.33 | $0.31 - $0.35 | -6.06% | Miss | N/A | 2 | N/A | Mar 6, 2020 | $62.27M |
| Sep 30, 2019 | -$0.03 | -$0.20 | N/A | +85.00% | Beat | N/A | N/A | N/A | Dec 2, 2019 | $36.23M |
| Jun 30, 2019 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 13, 2019 | $36.23M |
| Mar 31, 2019 | -$0.72 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2019 | $18.68M |
| Dec 31, 2018 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 30, 2019 | $62.45M |
| Sep 30, 2018 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 30, 2018 | $29.61M |
| Jun 30, 2018 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 30, 2018 | $31.61M |
| Mar 31, 2018 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 29, 2018 | $20.90M |
Annual EPS
EPS for the fiscal year ended Jun 30, 2026 was -$0.84, after -$0.80 the year before. It was -$0.17 for the year ended Jun 30, 2018, the oldest of the 9 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jun 30, 2026 | -$0.84 | N/A |
| Jun 30, 2025 | -$0.80 | -1434.2% |
| Jun 30, 2024 | $0.06 | -76.9% |
| Jun 30, 2023 | $0.26 | N/A |
| Jun 30, 2022 | -$0.14 | N/A |
| Jun 30, 2021 | -$0.16 | -166.7% |
| Jun 30, 2020 | $0.24 | N/A |
| Jun 30, 2019 | -$0.93 | N/A |
| Jun 30, 2018 | -$0.17 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 2,500 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 2,496 | 6 | |
| 2026Q1 | Mar 31, 2026 | 2,047 | 4 | |
| 2025Q4 | Dec 31, 2025 | 3,815 | 7 | |
| 2025Q3 | Sep 30, 2025 | 6,975 | 10 | |
| 2025Q2 | Jun 30, 2025 | 7,587 | 9 | |
| 2025Q1 | Mar 31, 2025 | 5,583 | 8 | |
| 2024Q4 | Dec 31, 2024 | 7,533 | 9 | |
| 2024Q3 | Sep 30, 2024 | 6,689 | 8 |
2026Q3 Earnings Call
Opening remarks
Paula Savanti Head of Investor Relations Thank you, and good morning, everyone. Welcome to Bioceres Crop Solutions Third Fiscal Quarter 2026 Earnings Conference Call. Our prepared remarks today will be led by our Chief Executive Officer, Federico Trucco; our General Counsel, Jose Roque; and our Chief Financial Officer, Ezequiel Simmermacher. All of them will be available for the Q&A session following the presentation. During this call, we will be making forward-looking statements. These statements are based on current expectations and assumptions that are subject to various risks and uncertainties. I refer you to the forward-looking statements section of the earnings release and presentation as well as the recent filings with the SEC. We assume no obligation to update or revise any forward-looking statements to reflect new or changed circumstances. In today's presentation, we will be making references to certain non-GAAP financial measures. Reconciliations of the non-GAAP measures can be found in our earnings press release. This conference call is being webcast, and the link is available at our Investor Relations website. It is now my pleasure to turn the call over to Federico.
Federico Trucco Chief Executive Officer Thanks, Paula, and good morning to everyone. Thanks for joining us today. Please turn to Slide 3 for today's key business and financial highlights. This quarter reflects a period of transition and operational refocusing for the company, while it is historically our weakest quarter from a baseline business perspective. Total revenues and gross profits showed a decline compared to the same quarter last year, which was partially offset by an improvement in operational expenses. Net loss was $10 million, primarily reflecting lower gross profit as well as increased financial expenses, all of which will be described in greater detail later in the presentation. Also, in the last 3 years, we have booked profits from IP rights and other commercial arrangements in this quarter, which helped us offset baseline operating losses. Although we continue to explore strategic arrangements with our partners on a regular basis and see these as a recurrent source of profitability, this year, the timing of profit-generating arrangements did not coincide with the initial months of the calendar year. As I have stated in my message to shareholders of March 16, we recognize the significance of the events surrounding Pro Farm and the uncertainty generated by the ongoing litigation process. Jose Roque, our General Counsel, will now provide an update of the ongoing litigation. Please turn to Slide 4.
Jose Roque General Counsel Thank you, Federico, and good morning to everyone on the call. As previously disclosed, in November 2025, four holders of secured notes issued under our note purchase agreements dated August 2022 filed a lawsuit in New York against the company and certain guarantor affiliates.
Frequently Asked Questions About BIOX
How often does BIOX beat earnings estimates?
Bioceres Crop Solutions beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate, with an average surprise of -403.20%.
BIOX pages: Overview, Earnings, Financials, Valuation